It was meant as an exaggeration, basically. It sho

It was meant as an exaggeration, basically. It should take them longer than two weeks. I don’t know exactly how long but the point of my comment was that they will probably find a way to enroll quickly. The link someone posted of their trial design showed a very large number of sites. Partner that with a much larger department of people at both Gilead and Lily working on this with all of their history and relationships and they could “quickly” get to some preliminary data. If that happens and it’s even remotely positive I would imagine the fda once again touting it to the world with an early approval. They seem dead set on this path forward. We’ll throw a really positive monkey wrench in their plans at some point in the near future with a better treatment, but it honestly wouldn’t surprise me if we’ll still be trying to get our last couple patients enrolled before analysis and they’ve leapfrogged us for the combo approval. Like I said before, we are in a “when, not if” scenario with Leronlimab. I’m very excited about it but can envision at least one more frustrating moment like I just mentioned happening before our coming out party. Man do I hope I’m wrong. Either way it’s going to be a hell of a party!